U

Biological Industries

Tissue Culture Products for Research and Diagnostics
Startup Acquired Founded 1990 Health Tech & Life Sciences
Last Update Feb 26, 2025

Biological Industries News

7 articles
Dec 5, 2019 · www.businesswire.com
Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries
Jun 7, 2018 · www.hartfordbusiness.com
growth-positive
Cromwell life sciences firm inks distribution deal
Cromwells Biological Industries has entered into a distribution partnership with Primorigen, a Wisconsin company, to distribute Primorigens protein matrix for stem cell culture called Vitronectin XF. The financial terms of the deal were not disclosed. This partnership will allow the scientific community to leverage the benefits of Vitronectin XF.
Partners
Jun 6, 2018 · www.businesswire.com
Biological Industries USA Adds Vitronectin XF™ to its Stem Cell Portfolio Through Agreement with Primorigen Biosciences, Inc.
May 9, 2018 · www.businesswire.com
Biological Industries USA Announces Initial Winners of MSC Research Awards
Jan 23, 2018 · www.businesswire.com
Biological Industries USA Announces Mesenchymal Stromal and Stem Cell Research Award, Including Conference Travel, Laboratory Reagents, and Potential Publicity for Researchers
Mar 6, 2017 · blog.bioind.com
growth-positive
Biological Industries USA Signs Agreement With Mill Creek Life Sciences To Add PLTMax Human Platelet Lysate To Its Growing Stem Cell Portfolio - Biological Industries
Biological Industries USA (BI-USA) has announced a distribution agreement with Mill Creek Life Sciences LLC for the distribution of PLTMax® Human Platelet Lysate. This product offers superior growth and cellular properties for the culture of human mesenchymal stem cells. The agreement allows BI-USA to expand its stem cell portfolio reach in the US and beyond. The partnership aims to serve the needs of the stem cell industry through application development. Mill Creek Life Sciences provides tools to support the development and application of cellular and biological therapeutics. The agreement is expected to have a positive impact on the growth of Biological Industries USA.
Partners
Sep 16, 2013 · www.flowerweb.com
growth-positive
Long term agreement between Bartels Stek and Biological Industries (Israel) regarding Gypsophila
Bartels Stek and Biological Industries Ltd (BI) have signed a long-term agreement for the exclusive worldwide distribution of all Gypsophila varieties by Bartels Stek. Bartels Stek will handle worldwide sales, license, and marketing activities for all Gypsophila varieties of BI, except for Israel. The agreement is expected to improve BIs worldwide distribution and benefit growers around the world. Bartels Stek specializes in perennial and fillers, and Gypsophila will be a great addition to their range of filler crops. The teams of BI and Bartels Stek will work closely together to offer customers the best possible service. Testing of all selections will take place in Israel and Kenya.
Partners